TrialIndian journal of ophthalmology2021

Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma.

Sherein M Hagras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.